ArticleAmerican journal of respiratory and critical care medicine2023
Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma.
Brian Lipworth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.